The rationale for targeting TGF-beta in chronic liver diseases

Author(s):
Giannelli, G.; Mikulits, W.; Dooley, S.; Fabregat, I.; Moustakas, A.; Dijke, P. ten (0000-0002-2875-4723); Portincasa, P.; Winter, P.; Janssen, R.; Leporatti, S.; Herrera, B.; Sanchez, A.
Published
2016
Publication type
Article / Letter to editor
EMTgalunisertibHCCtargeting TGF-beta RITGF-betatumour progression
Date issued
2016-04-30
Language
English
Is part of
European Journal of Clinical Investigation (2016), Vol. 46, no. 4, p. 349-361
hdl
1887/111873
doi
10.1111/eci.12596